Henderson Beric R
Westmead Institute for Cancer Research, Westmead Millennium Institute at Westmead Hospital, University of Sydney, Darcy Road, P.O. Box 412, Westmead, NSW 2145, Australia.
Scientifica (Cairo). 2012;2012:796808. doi: 10.6064/2012/796808. Epub 2012 Oct 18.
Inherited mutations in the BRCA1 gene predispose to a higher risk of breast/ovarian cancer. The BRCA1 tumor suppressor is a 1863 amino acid protein with multiple protein interaction domains that facilitate its roles in regulating DNA repair and maintenance, cell cycle progression, transcription, and cell survival/apoptosis. BRCA1 was first identified as a nuclear phosphoprotein, but has since been shown to contain different transport sequences including nuclear export and nuclear localization signals that enable it to shuttle between specific sites within the nucleus and cytoplasm, including DNA repair foci, centrosomes, and mitochondria. BRCA1 nuclear transport and ubiquitin E3 ligase enzymatic activity are tightly regulated by the BRCA1 dimeric binding partner BARD1 and further modulated by cancer mutations and diverse signaling pathways. This paper will focus on the transport, dynamics, and multiple intracellular destinations of BRCA1 with emphasis on how regulation of these events has impact on, and determines, a broad range of important cellular functions.
BRCA1基因的遗传性突变会使患乳腺癌/卵巢癌的风险更高。BRCA1肿瘤抑制因子是一种含有1863个氨基酸的蛋白质,具有多个蛋白质相互作用结构域,有助于其在调节DNA修复与维持、细胞周期进程、转录以及细胞存活/凋亡等方面发挥作用。BRCA1最初被鉴定为一种核磷蛋白,但后来发现它含有不同的转运序列,包括核输出信号和核定位信号,使其能够在细胞核和细胞质内的特定位点之间穿梭,包括DNA修复位点、中心体和线粒体。BRCA1的核转运和泛素E3连接酶活性受到BRCA1二聚体结合伴侣BARD1的严格调控,并进一步受到癌症突变和多种信号通路的调节。本文将重点关注BRCA1的转运、动态变化以及多个细胞内定位,着重探讨这些过程的调控如何影响并决定一系列重要的细胞功能。